<DOC>
	<DOCNO>NCT00070642</DOCNO>
	<brief_summary>To determine safety , tolerability effect CPG 7909 ( study drug ) give chemotherapy patient melanoma .</brief_summary>
	<brief_title>CPG 7909 Injection Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Histologically cytologically confirm melanoma metastatic . Measurable disease accord RECIST criterion . Karnofsky Performance Status &gt; 70 . Prior treatment antineoplastic biologic chemotherapy recurrent metastatic disease ( except one course adjuvant immunotherapy and/or adjuvant chemotherapy DTIC ) . Suspected known CNS metastasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Immunotherapy , skin cancer</keyword>
</DOC>